Colon Cancer Clinical Trial

Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors

Summary

The purpose of this research study is to determine whether using the physical activity index screener, exercise coaching, and self-monitoring will increase physical activity and reduce time spent sitting or being inactive in patients who had breast or colon cancer.

View Full Description

Full Description

To assess the feasibility (participation rate, adherence, and retention) of the Physical Activity Index (PAI) intervention in breast and colon cancer survivors supported by exercise coaching and self-monitoring tools.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Survivors of breast or colon cancer (stages 0-III) diagnosed within the last three years prior to enrollment.
Completed primary treatment (surgery, chemotherapy, and/or radiation) at least 3 months prior to enrollment.
At least 50 years of age or older.
Access to internet or cellular plan for video calls.
Being willing and able to comply with the approved protocol and able to be to sign an IRB-approved informed consent document directly.
Able to read and speak English

Exclusion Criteria:

Participants with metastatic disease.
Participants with recurrence or diagnosis of a different cancer.
Participants receiving treatment other than maintenance therapy for their primary cancer (breast or colon).
Participants has prior conditions that contraindicate exercise as determined by treating physician.
Participants has gross cognitive impairment as determined by treating physician.

Study is for people with:

Colon Cancer

Estimated Enrollment:

20

Study ID:

NCT06340503

Recruitment Status:

Not yet recruiting

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem North Carolina, 27157, United States More Info
Principal Investigator
Contact
Shirley Bluethmann, PhD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

20

Study ID:

NCT06340503

Recruitment Status:

Not yet recruiting

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.